Camrelizumab plus famitinib in patients with advanced or metastatic kidney cancer
An ongoing phase 2 study of a combination of two [...]
Treatment with stereotactic body radiotherapy plus TKIs or immunotherapy is safe and may improve survival of metastatic kidney cancer patients
Two small studies looked at the addition of a type [...]
Potential prognostic biomarker for kidney cancer
A recent study, published in the European Review for Medical [...]
